Sue Desmond-Hellmann
Also known as Susan Desmond-Hellmann
Sue Desmond-Hellmann is an oncologist and biotechnology executive who helps govern OpenAI as a member of its board. She earned her medical degree at the University of Nevada, Reno in 1982, joined Genentech in 1995, and served there as president of product development until 2009, with a role in the first gene-targeted cancer therapies Avastin and Herceptin. In 2009, she became the first woman to serve as chancellor of UCSF, and from 2014 to 2020 she was CEO of the Bill & Melinda Gates Foundation. OpenAI named her to its board in March 2024, and she is one of the independent directors of the OpenAI Foundation.
- Now at
- University of California, San Francisco, OpenAI, OpenAI Foundation, Pfizer, National Resilience and Stand Up to Cancer
- Born
- 1958
- Works
- 4
Years link to their sources. Publication numbers from OpenAlex, as of 22 October 2026. Citations and h-index are hidden because this OpenAlex record may be incomplete or mix in other authors.
Timeline
-
1978–1982
Medical degree in Reno
She grows up in Reno, Nevada, and earns a bachelor of science in pre-medicine from the University of Nevada, Reno in 1978 and a medical degree there in 1982. She comes to UCSF as an intern in 1982, serves as chief resident, and also earns a master's degree in public health from UC Berkeley.
-
1995–2009
Genentech product development
She joins Genentech as a clinical scientist in 1995, becomes chief medical officer in 1996, and executive vice president of development and product operations in 1999. From March 2004 to 2009, she is president of product development, with a role in the development of two of the first gene-targeted cancer therapies, Avastin and Herceptin.
-
2009–2014
Chancellor of UCSF
In August 2009, she is named UCSF's ninth chancellor and becomes the first woman to hold the post. In 2011, she co-chairs a National Academy of Sciences committee that produces the report Toward Precision Medicine: Building a Knowledge Network for Biomedical Research and a New Taxonomy of Disease, and she steps down as chancellor in March 2014.
-
2010
Election to two academies
She is inducted into the American Academy of Arts and Sciences and elected to the Institute of Medicine in 2010.
-
2014–2020
CEO of the Gates Foundation
The Bill & Melinda Gates Foundation announces her as its next CEO in December 2013, and she takes the role in May 2014 as the first physician to lead it. In December 2019, she announces she will step down, citing health and family reasons, and Mark Suzman succeeds her in 2020.
-
March 2024
Joining OpenAI's board
OpenAI names her to its board in March 2024, together with Nicole Seligman and Fidji Simo, as Sam Altman rejoins the board. She also serves on Pfizer's board and on the President's Council of Advisors on Science and Technology.
-
2024
A Clark Kerr Award
She receives the Clark Kerr Award for distinguished leadership in higher education from the UC Berkeley Academic Senate in 2024.
-
As of October 2026
OpenAI Foundation director
She is one of the independent directors of the OpenAI Foundation, the nonprofit that controls OpenAI Group PBC after OpenAI's October 2025 recapitalization. She also serves on the boards of Pfizer, National Resilience and Stand Up to Cancer, advises GV, Lazard and BDT-MSD, and is an adjunct professor at UCSF.
Career
- Since 2025OpenAI FoundationIndependent Director
- Since 2024OpenAIBoard Member
- Since 1982University of California, San FranciscoIntern, Chancellor
- NowPfizerBoard Member
- NowNational ResilienceBoard Member
- NowStand Up to CancerBoard Member
- 2014–2020Bill & Melinda Gates FoundationCEO
- 2011National Academies of Sciences, Engineering, and MedicineCommittee Co-Chair
- 1995–2009RocheClinical Scientist, Chief Medical Officer
- President's Council of Advisors on Science and TechnologyMember
Education
- 1982University of Nevada, RenoMedical degree
- 1978University of Nevada, RenoB.S. in pre-medicine
- University of California, BerkeleyMaster's degree in public health
Sources and credits
Photo: We have no published photo of Sue Desmond-Hellmann yet. Send us a free-licensed photo.
- Susan Desmond-Hellmann - Biography - A History of UCSF
- Sue Desmond-Hellmann - Wikipedia
- Bill And Melinda Gates Foundation Names New CEO : The Two-Way : NPR
- Gates Foundation CEO Susan Desmond-Hellmann to step down
- Sam Altman rejoins OpenAI board of directors as investigation into his ouster comes to a close
- OpenAI Names Paul Christiano to Foundation Board and Safety Committee – Unite.AI
- Sue Desmond-Hellmann, MD, MPH | UCSF Institute for Global Health Sciences

